Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital

References

• World Health Organization. Antimicrobial resistance: global report on surveillance. 2014 [cited 2016 Aug 21]. Available from: http://www.who.int/mediacentre/news/release/2014
   Google Scholar
• Founou RC, Founou LL, Essack SY, et al. Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis. PLoS One. 2017;12(12):e0189621.
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Gilbert DN, Spellberg B. Seven ways to preserve the miracle of antibiotics. Clin Infect Dis. 2013;56(10):1445–1450.
   PubMed Web of Science ®Google Scholar
• Bell BG, Schellevis F, Stobberingh E, et al. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13.
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Davey PG, Grundmann H. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med. 2011;8(10):e1001104.
   PubMed Web of Science ®Google Scholar
• O’Neill J. Securing new drugs for future generations: the pipeline of antibiotics. The review of antimicrobial resistance. Available from: https://amr-review.org/sites/default/files/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf
   Google Scholar
• Gandra S, Barter DM, Laxminarayan R. Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect. 2014;20(10):973–980.
   PubMed Web of Science ®Google Scholar
• Jinks T, Lee N, Sharland M, et al. A time for action: antimicrobial resistance needs global response. Bull World Health Organ. 2016;94(8):558–a.
   PubMed Web of Science ®Google Scholar
• Pulcini C, Mainardi JL. Antimicrobial stewardship: an international emergency. Clin Microbiol Infect. 2014;20(10):947–948.
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742–750.
   PubMed Web of Science ®Google Scholar
• Shallcross LJ, Howard SJ, Fowler T, et al. Tackling the threat of antimicrobial resistance: from policy to sustainable action. Philosophical Trans Royal Soc B: Biol Sci. 2015;370(1670):2014008.
   Web of Science ®Google Scholar
• WHO. Global action plan on antimicrobial resistance. Available from: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/
   Google Scholar
• Goff DA, Mendelson M. Antibiotic stewardship hits a homerun for patients. Lancet ID. 2017;17(9):892–893.
   PubMed Web of Science ®Google Scholar
• Kimang’a AN. A situational analysis of antimicrobial drug resistance in Africa: are we losing the battle? Ethiop J Health Sci. 2012;22(2):135–143.
   PubMedGoogle Scholar
• Federal Ministries of Agriculture, Environment and Health of Nigeria. Antimicrobial use and resistance in Nigeria: situation analysis and recommendations. 2017 [cited 2018 Jan 11]. Available from: http://www.ncdc.gov.ng/themes/common/docs/protocols/56_1510840387.pdf
   Google Scholar
• Okesola A O, Aroundegbe T I. Antibiotic resistance pattern of uropathogenic Escherichia coli in South West Nigeria. Afr J Med Med Sci. 2011;40:235–238.
   PubMedGoogle Scholar
• Muoneke V, Ibekwe M, Ibekwe R. Childhood urinary tract infection in abakaliki: etiological organisms and antibiotic sensitivity pattern. Ann Med Health Sci Res. 2012;2:29–32.
   PubMedGoogle Scholar
• Iroezindu M O, Chima E I, Isiguzo G C., et al. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study. Scand J Infect Dis. 2014;46:875–887.
   PubMed Web of Science ®Google Scholar
• Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Ther Adv Drug Saf. 2014;5(6):229–241.
   PubMedGoogle Scholar
• van de Sande-Bruinsma N, Grundmann H, Verloo D, et al. European antimicrobial resistance surveillance system group; European surveillance of antimicrobial consumption project group. Antimicrobial drug use resistance Europe. Emerg Infect Dis. 2008;14:1722–1730.
   PubMed Web of Science ®Google Scholar
• Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev. 2010;74:417–433.
   PubMed Web of Science ®Google Scholar
• Oduyebo O O, Onwuezobe I A, Olayemi S O. et al. Correlating antibiotic consumption with antimicrobial resistance of uropathogens in a university teaching hospital in Lagos, Nigeria. Niger J Clin Pract. 2008;11:305–308.
   PubMed Web of Science ®Google Scholar
• Godman B, Fadare J, Kibuule D, et al. Initiatives across countries to reduce antibiotic utilization and resistance patterns; impact and implications. ln: Arora G, Sajid A, Kalia VC, editors. Drug resistance in bacteria, fungi, malaria, and cancer. Springer. Nature ISBN 978-3-319-48682-6. Available from: https://purestrathacuk/portal/en/publications/initiatives-across-countries-to-reduce-antibiotic-utilization-and-resistance-patternsbb445446-fd1d-47b3-8f91-def5d9e5e3db/exporthtml
   Google Scholar
• Huttner B, Goossens H, Verheij T, et al. Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis. 2010;10(1):17–31.
   PubMed Web of Science ®Google Scholar
• Nuermberger EL, Bishai WR. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis. 2004;38(Suppl 4):S363–S71.
   PubMedGoogle Scholar
• Md Rezal R S, Hassali M A, Alrasheedy A A, et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti Infect Ther. 2015;13:665–680.
   PubMed Web of Science ®Google Scholar
• Moro ML, Marchi M, Gagliotti C, et al. Why do paediatricians prescribe antibiotics? Results of an Italian regional project. BMC Pediatr. 2009 Nov;6(9):69.
   Google Scholar
• Lopez-Vazquez P, Vazquez-Lago JM, Figueiras A. Misprescription of antibiotics in primary care: a critical systematic review of its determinants. J Eval Clin Pract. 2012;18(2):473–484.
   PubMed Web of Science ®Google Scholar
• van Buul LW, Sikkens JJ, van Agtmael MA, et al. Participatory action research in antimicrobial stewardship: a novel approach to improving antimicrobial prescribing in hospitals and long-term care facilities. J Antimicrob Chemother. 2014;69(7):1734–1741.
   PubMed Web of Science ®Google Scholar
• Charani E, Castro-Sanchez E, Sevdalis N, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of “prescribing etiquette”. Clin Infect Dis. 2013;57(2):188–196.
   PubMed Web of Science ®Google Scholar
• Calbo E, Alvarez-Rocha L, Gudiol F, et al. A review of the factors influencing antimicrobial prescribing. Enferm Infecc Microbiol Clin. 2013 Sep;31(Suppl 4):12–15.
   PubMedGoogle Scholar
• Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
   PubMed Web of Science ®Google Scholar
• Nathwani D, Sneddon J, Malcolm W, et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents. 2011;38:16–26.
   PubMed Web of Science ®Google Scholar
• Pulcini C. Antibiotic stewardship: update and perspectives. Clin Microbiol Infect. 2017;23(11):791–792.
   PubMed Web of Science ®Google Scholar
• Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23(11):812–818.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global burden of diseases. 2004 [cited 2017 Jan 3]. Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_part4.pdf
   Google Scholar
• African population. 2017 [cited 2017 Jan 3]. Available from: http://worldpopulationreview.com/continents/africa-population/
   Google Scholar
• Collins J. Professionalism and physician interactions with industry. J Am Coll Radiol. 2006;3(5):325–332.
   PubMedGoogle Scholar
• Fleischman W, Agrawal S, King M, Venkatesh AK, Krumholz HM, McKee D, et al. Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study. BMJ. 2016;354:i4189.
   PubMedGoogle Scholar
• Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training. a thematic review. J Gen Intern Med. 2005;20(8):777–786.
   PubMed Web of Science ®Google Scholar
• Fischer MA, Keough ME, Baril JL, et al. Prescribers and pharmaceutical representatives: why are we still meeting? J Gen Intern Med. 2009;24(7):795–801.
   PubMed Web of Science ®Google Scholar
• Orlowski JP, Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. There’s no such thing as a free lunch. Chest. 1992;102(1):270–273.
   PubMed Web of Science ®Google Scholar
• Gustafsson LL, Wettermark B, Godman B, et al. The ‘wise list’- a comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin Pharmacol Toxicol. 2011;108(4):224–233.
   PubMed Web of Science ®Google Scholar
• Bjorkhem-Bergman L, Andersen-Karlsson E, Laing R, et al. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur J Clin Pharmacol. 2013;69(Suppl 1):73–78.
   PubMed Web of Science ®Google Scholar
• Fadare J, Ogunleye O, Enato E, et al. Presence and functionality of drug and therapeutics committees (DTC) in selected Nigerian hospitals – results of a pilot study. MURIA Conference PV NCD DU Studies. 2016: 2 Available from: http://muria.nmmu.ac.za/2nd-MURIA-Training-Workshop-and-Symposium,-25-27-J
   Google Scholar
• Fadare J, Ogunleye O, Muller A, et al. The current state of antimicrobial stewardship programs in Nigerian tertiary healthcare facilities. MURIA 3 2017; 9. Available from: http://muria.mandela.ac.za/muria/media/Store/documents/Abstract%20book%20-%20MURAI%203/MURIA3-AbstractBook-July-2017.pdf
   Google Scholar
• Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017 Feb 09;2:Cd003543.
   PubMed Web of Science ®Google Scholar
• Nasr Z, Paravattil B, Wilby KJ. The impact of antimicrobial stewardship strategies on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East: a systematic review. East Mediterr Health J. 2017 Aug 20;23(6):430–440.
   PubMed Web of Science ®Google Scholar
• Meyer JC, Schellack N, Stokes J, et al. Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study. Front Pharmacol. 2017;8:751.
   PubMed Web of Science ®Google Scholar
• Afriyie DK, Amponsah SK, Dogbey J, et al. A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications. Hosp Pract. 2017;45(4):143–149.
   PubMedGoogle Scholar
• Fadare JO, Adeoti AO, Desalu OO, et al. The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians. Expert Rev Pharmacoecon Outcomes Res. 2016;16(5):639–650.
   PubMed Web of Science ®Google Scholar
• Ezenduka C, Uboch V, Ogbonna BO. The utilization pattern and costs analysis of psychotropic drugs at a neuropsychiatric hospital in Nigeria. Br J Pharm Res. 2014;4(3):325–337.
   Google Scholar